Infinite (U1286 Inserm | Univ. Lille | CHU Lille)

Translational Research to understand the origins, mechanisms and consequences of chronic inflammation and to develop new associated therapeutics and biomarkers

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

Séminaire Jeudi 25 janvier 2024 à 11h30
@CHU_lille
@NeuroendoLille
@CognitionLille
@inserm_lille
@PasteurLille
@Canther_Lille

[David Launay @DLaunay]

Great work and great collaboration for
@LilleInfinite and @Servier
on antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis https://t.co/bzn2whqKZN @NatureComms @RechercheUlille @CHU_Lille @UFR3S_ULille 1/4

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

Séminaire jeudi 26 jan, 13h30: GnRH & trisomie
Amphi Pauling, Fac. de Pharma/Zoom: https://t.co/x1xwvB345a par Vincent PREVOT @NeuroendoLille, Dir. de Recherche @CognitionLille @univ_lille @inserm_lille @CHU_lille @PasteurLille

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

#SFBBM #article-of-the-month (https://t.co/KzM4hQ1Wp9) 🏆 to Guillaume Lacroix 👏 for his study in iScience on 🐭 #preterm #birth, #mucus and #mucins. So proud.
@medecine_Ulille @univ_lille @Inserm @CHU_Lille

[Vincent Sobanski @VSobanski]

☀️ Préparez la rentrée pendant la pause estivale en vous inscrivant au DU "Intelligence artificielle en santé" @medecine_Ulille
➡️ 4ème année d'expérience !
@univ_lille @CHU_Lille @Inria_Lille @Inserm @CNRS_HdF @PasteurLille @InstUnivFr @lillefrance @MEL_Lille @hautsdefrance

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

Bravo à Nathan qui publie dans @ms_MedSci (Paris) en Open Access une synthèse https://t.co/HalGWhfDxF en français sur la #fibrose #pulmonaire #idiopathique.
@Inserm
@medecine_Ulille
@CHU_Lille
@UFR3S_ULille

[David Launay @DLaunay]

✨Our new review published in @FrontImmunol
Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis? 🤔🧐
Come & see terrific figures by our PhD students Aurélien and Louisa 🤩
@medecine_Ulille @univ_lille @Inserm @CHU_Lille @InstUnivFr
https://t.co/y55IXTd1Y2

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

Glad to share our recent paper about Porous #cervical #mucus #plug, #vaginal #infection and #preterm birth.
@Inserm @CHU_Lille @MITglycobio @SFGlycobiology @SRIWomensHealth @ThomasCrouzier @CaroWerlang

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

We https://t.co/Jme4Vj6UzH showed in @IScience paper that gel-forming #mucins are essential for the #mucus plug of the cervical canal during #pregnancy to prevent vaginal bacteria from ascending into the uterus and thus prevent #preterm births.
@Inserm @CHU_Lille @AJOG_thegray

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

We https://t.co/Jme4Vj6UzH showed in @IScience paper that gel-forming #mucins are essential for the #mucus plug of the cervical canal during #pregnancy to prevent vaginal bacteria from ascending into the uterus and thus prevent #preterm births.
@Inserm @CHU_Lille @AJOG_thegray

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

We https://t.co/Jme4Vj6UzH showed in @IScience paper that gel-forming #mucins are essential for the #mucus plug of the cervical canal during #pregnancy to prevent vaginal bacteria from ascending into the uterus and thus prevent #preterm births.
@Inserm @CHU_Lille @AJOG_thegray

[Inserm @Inserm]

L’infection par le #SARSCoV2 s'accompagne de la fabrication de composés spécifiques par nos cellules, les céramides. Une synthèse de littérature par @inserm @aphp @Univ_Paris montre que ce sont de bons biomarqueurs de sévérité de la maladie et une cible thérapeutique intéressante

[David Launay @DLaunay]

Feel free to participate to our new research topic in @FrontImmunol : The Pathophysiological Role of the Immune System in #scleroderma! https://t.co/xFguGyYGCu We welcome from Original Research to Review Articles ! please RT @VSobanski @LilleInfinite

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

https://t.co/mGmvThazbd

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

Very exciting GGMM-SFCI 2021 ended today!! See you in 2 years for next adventure!! @SFCi_fr @LILLIADlci @MatthieuMontes @hautsdefrance @sebfiorucci @Hello_Lille @univ_lille
https://t.co/723prHvEmU

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

We organize an international symposium on fibrosis on June 29th. Registration free but mandatory.
https://t.co/HOIPDhGkyW

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

https://t.co/uEN7BmLcwm

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

We organize the next big French meeting of computational chemistry on September 29th!!
#BigData #drugdiscovery #DeepLearning #Bioinformatics
@CHU_Lille @Inserm @univ_lille

[SFCi - Société Française de ChémoInformatique @SFCi_fr]

The next French days of chemoinformatics 😀

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

Mathilde Le Maître, doctorante d'INFINITE, est qualifiée pour la finale régionale de "Ma thèse en 180 secondes" : Etude des interactions entre les lymphocytes B et la peau au cours de la sclérodermie systémique. On la soutient tous le 24 mars à 16h !
https://t.co/mp4tDbiQfi

[Infinite (U1286 Inserm | Univ. Lille | CHU Lille) @LilleInfinite]

OFFRE D'EMPLOI
INFINITE recrute un gestionnaire administratif et financier, en CDD jusqu’au 31/12/2021, renouvelable.
👉https://t.co/UolMiCLN6E

[Pierre Bauvin @BauvinPierre]

My first first-author paper was published @LiverInt !
A tool to predict progression of NAFLD in severely obese patients, using a Markov Chain approach among bariatric surgery candidates #livertwitter #PreciNASH
@LilleInfinite @CHU_Lille @Inserm
https://t.co/rcpw0tg4yZ